Raymond James Financial
IDXX icon

Raymond James Financial’s Idexx Laboratories IDXX Stock Holding History

Raymond James Financial’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$153M Buy
272,955
+16,603
+6% +$10.6M 0.05% 362
2025
Q4 		$174M Sell
256,352
-16,239
-6% -$11.1M 0.05% 306
2025
Q3 		$174M Buy
272,591
+61,818
+29% +$37.5M 0.06% 303
2025
Q2 		$113M Buy
210,773
+17,517
+9% +$8.38M 0.04% 438
2025
Q1 		$81.2M Buy
193,256
+19,366
+11% +$8.41M 0.03% 503
2024
Q4 		$71.9M Buy
+173,890
New +$76.3M 0.03% 546

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Raymond James Financial's IDXX Position: Q1 2026 in Review

Raymond James Financial increased its Idexx Laboratories (IDXX) stake by 6.5% in Q1 2026, buying an estimated $10.6M and bringing the position to 272,955 shares worth $153M. The position accounts for 0.05% of the portfolio, ranked #362.

Raymond James Financial first reported a position in IDXX in Q4 2024 and has held it in 6 quarters since. The position peaked at $174M in Q4 2025. 1,314 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Raymond James Financial held 272,955 shares of Idexx Laboratories worth $153M as of Q1 2026.
  • Raymond James Financial bought 16,603 Idexx Laboratories shares in Q1 2026, an estimated $10.6M.
  • Idexx Laboratories made up 0.05% of Raymond James Financial's portfolio in Q1 2026, its #362 holding.
  • Raymond James Financial first reported a position in Idexx Laboratories in Q4 2024 and has held it in 6 quarters since.
  • Raymond James Financial's Idexx Laboratories position peaked at $174M in Q4 2025.
  • 1,314 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.